IntroductionEmphysema severity, emphysema heterogeneity, and pulmonary fissure completeness are predictors of response to endobronchial valve reduction treatment.1 In particular, the assessment of pulmonary fissure completeness is ofparamount importance due to […]
COVID-19 Special Feature – Healthcare Performance Insider How Imbio is using AI to close the gap of missed diagnosis Mike Hostetler lost his father when he was 13 to pancreatic […]
Accumen is helping healthcare get better, faster. Today, 3DR Labs, an Accumen Company, announced that it is now offering an artificial intelligence (AI) solution for diagnosing chronic lung disease through a new partnership with Imbio. 3DR Labs customers will have access to Imbio’s AI imaging technology effective immediately.
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment.
Imbio and Siemens Healthineers announced they are partnering to expand access to Imbio AI algorithms worldwide. Physicians will now be able to apply Imbio’s automated AI for quantitative image analysis directly through the Open Apps interface on Siemens’ syngo.via platform.
MINNEAPOLIS, Oct. 6, 2020 /PRNewswire/ — Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has partnered with Genentech, a member of the Roche Group, to develop quantitative imaging […]
Imbio is a medical imaging software company that offers fully automated 3D visualization and quantitative analysis solutions for lung and cardiothoracic imaging diagnostics. Designed to support radiologists and other clinicians, […]
MINNEAPOLIS, March 27, 2020 /PRNewswire/ — Flywheel Exchange, a research data platform and Imbio, an AI-driven medical imaging company specializing in lung analysis, have teamed up to help global researchers accelerate understanding […]
We’re proud to announce that we have signed a partnership agreement with US-based artificial intelligence (AI) provider Imbio. Together we will provide a simple way for NHS organisations to use […]
Chicago, IL – November 27, 2017: Advanced Visualization solution provider, TeraRecon (WWW.TERARECON.COM) today announced a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes the most content-rich […]